A hormone-free male birth control pill is undergoing clinical testing for the first time ever. The drug, called YCT-529, has performed incredibly well at limiting the production of sperm in mice and ...
A groundbreaking hormone-free male birth control pill, YCT-529, has transitioned from successful preclinical studies in mice to the initiation of human trials. Developed by YourChoice Therapeutics, ...
A non-hormonal, reversible male contraceptive pill with very few side effects might not be as far off as previously thought, early human trial results suggest. In a first-in-human study, a drug called ...
WARREN, Mich., May 21, 2025 /PRNewswire/ -- FemCap (https://femcap.com), an FDA-approved, prescription-only contraceptive device, is offering a groundbreaking alternative in the world of birth control ...
Women’s reproductive rights in the U.S. are narrowing. Meanwhile, 46% of all pregnancies in the U.S. are unintended, pointing to the stark evidence of the enduring need for access to effective, ...
The double-blind, placebo-controlled, phase 1 study is evaluating the safety, tolerability, and pharmacokinetics of YCT-529 in 16 healthy male participants. YCT-529 is a retinoic acid receptor-alpha ...
After successful preclinical studies in mice, researchers have this week begun the first human trials of a hormone-free male birth control pill. YCT-529, the drug being tested, is the first of its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback